Blackpoint Biotech is committed to revolutionising the medical cannabis industry by developing innovative and advanced products that deliver rapid onset of action, accurate dosing and high bioavailability. By addressing one of the largest gaps in the sector we aim to provide safe and controlled medical cannabis solutions that truly benefit patients.
We believe cannabinoids can be an effective treatment for certain medical conditions. To fully benefit - as with any medication - doctors and patients require the ability to deliver dosages that are reliable, controllable and consistent. Blackpoint Biotech’s medical cannabinoid inhalers and sublingual sprays provide this.